5-Fluorouracil and 5-formyltetrahydrofolate in advanced malignancies.
Becher
R
R
Innere Universitätsklinik (Tumorforschung), Westdeutsches Tumorzentrum, FRG.
Kurschel
E
E
Wandl
U
U
Kloke
O
O
Scheulen
M
M
Weinhardt
O
O
Höffken
K
K
Niederle
N
N
Khan
H
H
Bergner
S
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy; D004334:Drug Administration Schedule; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage / Q000031:analogs & derivatives; D008297:Male; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011471:Prostatic Neoplasms / Q000188:drug therapy
C010161:10-formyltetrahydropteroylglutamic acid; D002955:Leucovorin; D005472:Fluorouracil